论文部分内容阅读
近几年虽然在溃疡病治疗的研究取得了不少进展,但其疗效不十分理想。笔者近两年试用吡哌酸治疗溃疡病48例并与同期内甲氰咪呱组50例对照观察取得了较好疗效,现报告如下。 资料与方法 一、临床资料 48例均系内镜检查有活动性溃疡或(和)X线钡餐检查有壁龛者,按就诊次序随机分吡哌酸组和甲氰咪呱组。吡哌酸组48例病人中,男28例,女20例,年龄最小18岁,最大71岁;类型:胃溃疡16例,十二指肠溃疡28例,复合溃疡4例;病程最短2年,最长21年;甲氰咪呱组年龄、溃疡类型、病程及合并症同吡哌酸组相似。
Although in recent years in the treatment of ulcer disease has made a lot of progress, but its efficacy is not very satisfactory. In the past two years, the author trial of piperacillin in the treatment of 48 cases of ulcer and with the same period of cromolyn group 50 cases of controlled observation achieved good results, are as follows. Materials and Methods First, the clinical data of 48 cases were active endoscopic ulcer or (and) X-ray barium meal were niche, according to the order of treatment randomly divided into pipemidic acid group and cromolyn group. Piperacillin group of 48 patients, 28 males and 20 females, the youngest 18 years old, maximum 71 years old; type: 16 cases of gastric ulcer, duodenal ulcer in 28 cases, 4 cases of complex ulcer; the shortest course of 2 years , Up to 21 years; cimetidine group age, ulcer type, duration and complications with the same group of pipemidic acid.